The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells
André Fedier(University of Basel), Daniel Fink(Cornell University)
Cited by 37
Related Papers
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
|Cancer Cell|2021|140
Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells
|Fertility and Sterility|2010|46
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells
|International Journal of Oncology|2009|10
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
|International Journal of Oncology|2022|9
Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells
|Experimental and Therapeutic Medicine|2013|8